{"id":"W4281924689","doi":"10.1016/s0140-6736(22)00466-4","title":"Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial","year":2022,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":316,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Placebo; Maintenance therapy; Crohn's disease; Internal medicine; Clinical trial; Physical therapy; Disease; Chemotherapy; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002002049,0.00143324,0.003871687,0.0003031751,0.0004129331,0.001300286,0.0008861649,0.001995304,0.004304615],"category_scores_gemma":[0.00169352,0.0004862412,0.002754198,0.0003121584,0.001038113,0.001115155,0.0004522801,0.003120084,0.0008636716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006869769,"about_ca_system_score_gemma":0.0006731848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001148182,"about_ca_topic_score_gemma":0.002538588,"domain_scores_codex":[0.9994243,0.000268771,0.0000386486,0.00008302143,0.00005855253,0.0001267697],"domain_scores_gemma":[0.9988813,0.0003357235,0.0002867362,0.0001161513,0.00006732906,0.0003128625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9770584,0.001066794,0.0005490365,0.0007202943,0.001304078,0.00004169795,0.00005542846,0.0001502883,0.002449117,0.00006436403,0.001053949,0.0154867],"study_design_scores_gemma":[0.9686946,0.02566955,0.003808952,0.00004170954,0.0006627165,0.00005044343,0.00003255283,0.0001339394,0.0002457384,0.0001021063,0.0005414913,0.00001632139],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758127,0.01786416,0.0005486938,0.001246698,0.0005780646,0.0008409255,0.001289894,0.0001518918,0.001667119],"genre_scores_gemma":[0.9849208,0.00525717,0.001153259,0.002041657,0.0005931674,0.001057365,0.001491515,0.0000403355,0.003444667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004304615,"threshold_uncertainty_score":0.01440036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02881709370347897,"score_gpt":0.3055942787728437,"score_spread":0.2767771850693648,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}